Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.

Lipoprotein(a) [Lp(a)] concentration and apolipoprotein(a) [apo(a)] isoforms (identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE] and Western blotting) were determined in a group of 508 asymptomatic Caucasian members of the community and in 318 Caucasian patients with...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Farrer, M, Game, F, Albers, C, Neil, H, Winocour, P, Laker, M, Adams, P, Alberti, K
Formato:	Journal article
Idioma:	English
Publicado em:	1994

Registros relacionados

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
por: Farrer, M, et al.
Publicado em: (1993)

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
por: Farrer, M, et al.
Publicado em: (1994)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
por: Hopewell, J, et al.
Publicado em: (2014)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
por: Hopewell, J, et al.
Publicado em: (2014)

Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women.
por: Winocour, P, et al.
Publicado em: (1992)

High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery.
por: Skinner, J, et al.
Publicado em: (1999)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
por: Parish, S, et al.
Publicado em: (2018)

Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
por: Anastasiya Matveyenko, et al.
Publicado em: (2023-03-01)

Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery.
por: Skinner, J, et al.
Publicado em: (1997)

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels
por: Hopewell, J, et al.
Publicado em: (2010)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
por: Dick C. Chan, et al.
Publicado em: (2019-04-01)

Assessing the impact of blood sample type on the estimated prevalence of impaired glucose tolerance and diabetes mellitus in epidemiological surveys.
por: Farrer, M, et al.
Publicado em: (1995)

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
por: Stefania Lamon-Fava, et al.
Publicado em: (2011-06-01)

An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia
por: Kelly R. Atkinson, et al.
Publicado em: (2009-01-01)

Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year.
por: Farrer, M, et al.
Publicado em: (1995)

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
por: Ruotolo, G, et al.
Publicado em: (1998)

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis
por: K. I. Tebloev, et al.
Publicado em: (2005-10-01)

Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
por: Tom G Richardson, et al.
Publicado em: (2020-03-01)

Patient-related outcomes five years after coronary artery bypass graft surgery.
por: Skinner, J, et al.
Publicado em: (1999)

Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis
por: O I Afanasievа, et al.
Publicado em: (2016-09-01)

Rat plasma lipoproteins and apolipoproteins in experimental hypothyroidism.
por: L Dory, et al.
Publicado em: (1981-02-01)

The ratio of low-density lipoprotein cholesterol to apolipoprotein-B as a marker of low-density lipoprotein particle size
por: A. M. Kaneva, et al.
Publicado em: (2018-06-01)

Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a)
por: Santica M. Marcovina, et al.
Publicado em: (2022-08-01)

High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform.
por: Y Ma, et al.
Publicado em: (1994-06-01)

Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women.
por: D Applebaum-Bowden, et al.
Publicado em: (1989-12-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
por: N. E. Gavrilova, et al.
Publicado em: (2016-10-01)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
por: Yahui Lin, et al.
Publicado em: (2022-02-01)

The functions of apolipoproteins and lipoproteins in health and disease
por: Zijun Ma, et al.
Publicado em: (2024-10-01)

Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease
por: Johan Ljungberg, et al.
Publicado em: (2017-12-01)

Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
por: R W Mahley, et al.
Publicado em: (1995-04-01)

Clinical outcome measures eight years following Coronary Artery Bypass Grafting (CABG): A prospective cohort study
por: Mackin, P, et al.
Publicado em: (1999)

Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
por: Giedre Milinkeviciute, et al.
Publicado em: (2023-04-01)

Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I.
por: JC Khoo, et al.
Publicado em: (1990-04-01)

Structure of apolipoprotein B-100 in low density lipoproteins
por: Jere P. Segrest, et al.
Publicado em: (2001-09-01)

The correlation of apolipoprotein B, apolipoprotein B/apolipoprotein A-I ratio and lipoprotein(a) with myocardial infarction
por: Agoston-Coldea Lucia, et al.
Publicado em: (2008-12-01)

Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C
por: H H van Barlingen, et al.
Publicado em: (1996-04-01)

Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
por: Junfeng Zhang, et al.
Publicado em: (2023-11-01)

Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
por: Waldomiro Carlos Manfroi, et al.
Publicado em: (1999-06-01)

Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels
por: Jerome Robert, et al.
Publicado em: (2017-10-01)

Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins
por: L S Guo, et al.
Publicado em: (1980-11-01)